Mark Cuban says Trump's new drug platform could succeed if it forces pharma managers to change: 'If that happens, Trump gets all the credit'
Cuban's Cost Plus Drugs, which he founded in 2022, similarly provides direct-to-consumer discounted pharmaceuticals.
(Fortune, 2025-10-02T11:03:00Z)